Darolutamide receives EU approval in third indication for patients with advanced prostate cancer
July 21, 2025 03:30 ET Â | Source: Orion Oyj ORION CORPORATION PRESS…
Orion and Glykos announce the extension of their research collaboration and licensing agreement for the development of next-generation ADCs
June 17, 2025 02:00 ET Â | Source: Orion Oyj ORION CORPORATION PRESS…